Textbook of Interventional Cardiology

SECTION I: PATIENT SELECTION

1. Individualized Assessment for Percutaneous or Surgical Revascularization

2. Evidence-Based Interventional Practice

3. Diabetes

4. Prior Evaluation: Functional Testing, Multidetector Computed Tomography

5. Intracoronary Pressure and Flow Measurements

6. Contrast-Induced Acute Kidney Injury and the Role of Chronic Disease in Percutaneous Coronary Intervention

7. Radiation Safety During Cardiovascular Procedures

8. Preoperative Coronary Intervention

9. Gender and Ethnicity Issues in Interventional Cardiology

SECTION II: PHARMACOLOGIC INTERVENTION

10. Platelet Inhibitor Agents

11. Anticoagulation in Percutaneous Coronary Intervention

12. Lipid Lowering in Coronary Artery Disease

13. Thrombolytic Intervention

14. Other Adjunctive Drugs for Coronary Intervention: Beta-Blockers, Calcium Channel Blockers, and Angiotensin-Converting Enzyme Inhibitors

SECTION III: CORONARY INTERVENTION

15. The History of Balloon Angioplasty

16. Bare-Metal and Drug-Eluting Coronary Stents

17. Drug-Coated Balloons

18. Elective Intervention for Stable Angina or Silent Ischemia

19. Intervention for Non-ST-Segment Elevation Acute Coronary Syndromes

20. Percutaneous Coronary Intervention in Acute ST Segment Elevation Myocardial Infarction

21. Interventions in Cardiogenic Schock

22. Bifurcations and Branch Vessel Stenting

23. Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Stenosis

24. Complex and Multivessel Percutaneous Coronary Intervention

25. Intervention for Coronary Chronic Total Occlusion

26. Bypass Graft Intervention

27. The Thrombus-Containing Lesion

28. Complications of Percutaneous Coronary Intervention

29. Periprocedural Myocardial Infarction and Embolism-Protection Devices

30. Access Management and Closure Devices

31. Transradial Approach for Diagnostic Coronary Angiography and Intervention

32. The Role of the Cardiac Surgeon

33. Restenosis

34. Bioresorbable Coronary Scaffolds

35. The Role of Adjunct Devices: Atherectomy, Cutting Balloon, and Laser

36. Support Devices for High-Risk Percutaneous Coronary Interventions

37. Regional Centers of Excellence for the Care of Patients with Acute Ischemic Heart Disease

38. Post- Percutaneous Coronary Intervention Hospitalization, Length of Stay, and Discharge Planning

SECTION IV: PERIPHERAL VASCULAR INTERVENTIONS

39. Lower Extremity Interventions

40. Upper Extremities and Aortic Arch

41. Chronic Mesenteric Ischemia: Diagnosis and Intervention

42. Renal Artery Stenosis

43. Device Therapy for Resistant Hypertension

44. Thoracic and Abdominal Aortic Vascular Interventions

45. Venous Interventions

46. Carotid and Cerebrovascular Intervention

47. Stroke Centers and Interventional Cardiology

SECTION V: INTRACARDIAC INTERVENTION

48. Imaging for Intracardiac Interventions

49. Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect

50. Left Atrial Appendage Closure and Stroke: Local Device Therapy for Cardioembolic Stroke Protection

51. Mitral Valvuloplasty

52. Percutaneous Mitral Valve Repair

53. Transcatheter Aortic Valve Interventions: From Balloon Aortic Valvuloplasty to Transcatheter Aortic Valve Implantation

54. Pulmonary and Tricuspid Valve Interventions

55. Hypertrophic Cardiomyopathy

56. Pericardial Interventions

57. Transcatheter Therapies for Congenital Heart Disease

58. Stem Cell Therapy for Ischemic Heart Disease

SECTION VI: EVALUATION OF INTERVENTIONAL TECHNIQUES

59. Qualitative and Quantitative Coronary Angiography

60. Intravascular Ultrasound

61. High-Risk Vulnerable Plaques: Definition, Diagnosis, and Treatment

62. Optical Coherence Tomography

SECTION VII: OUTCOME EFFECTIVENESS OF INTERVENTIONAL CARDIOLOGY

63. Medical Economics in Interventional Cardiology

64. Quality of Care in Interventional Cardiology

65. Volume and Outcome

66. Interventional Heart Failure